381 related articles for article (PubMed ID: 16118343)
21. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
22. Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
Washio K; Uenaka M; Tanimura K; Deguchi M; Nishida K; Fujioka K; Yamada H
Kobe J Med Sci; 2021 Feb; 66(4):E153-E158. PubMed ID: 33994519
[TBL] [Abstract][Full Text] [Related]
23. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves' disease patients: a sequential study before, during and after pregnancy.
González-Jiménez A; Fernández-Soto ML; Escobar-Jiménez F; Glinoer D; Navarrete L
Thyroidology; 1993 Apr; 5(1):13-20. PubMed ID: 7508738
[TBL] [Abstract][Full Text] [Related]
24. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies.
Chung HK; Kim WB; Park DJ; Kohn LD; Tahara K; Cho BY
Thyroid; 1999 Apr; 9(4):393-9. PubMed ID: 10319947
[TBL] [Abstract][Full Text] [Related]
25. Management of Fetal and Neonatal Graves' Disease.
Léger J
Horm Res Paediatr; 2017; 87(1):1-6. PubMed ID: 27978517
[TBL] [Abstract][Full Text] [Related]
26. Management of neonates born to women with Graves' disease: a cohort study.
Besançon A; Beltrand J; Le Gac I; Luton D; Polak M
Eur J Endocrinol; 2014 Jun; 170(6):855-62. PubMed ID: 24670885
[TBL] [Abstract][Full Text] [Related]
27. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
[TBL] [Abstract][Full Text] [Related]
28. Therapy insight: management of Graves' disease during pregnancy.
Chan GW; Mandel SJ
Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):470-8. PubMed ID: 17515891
[TBL] [Abstract][Full Text] [Related]
29. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil.
Momotani N; Yamashita R; Makino F; Noh JY; Ishikawa N; Ito K
Clin Endocrinol (Oxf); 2000 Aug; 53(2):177-81. PubMed ID: 10931098
[TBL] [Abstract][Full Text] [Related]
30. Fetal goiter identified in a pregnant woman with triiodothyronine-predominant graves' disease: a case report.
Fujishima A; Sato A; Miura H; Shimoda Y; Kameyama S; Ariake C; Adachi H; Fukuoka Y; Terada Y
BMC Pregnancy Childbirth; 2020 Jun; 20(1):344. PubMed ID: 32493403
[TBL] [Abstract][Full Text] [Related]
31. Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease.
McNab T; Ginsberg J
Clin Invest Med; 2005 Jun; 28(3):127-31. PubMed ID: 16021986
[TBL] [Abstract][Full Text] [Related]
32. [Maternal and cord blood thyroid hormones in Graves' disease and fetal states].
Koike S; Aoyama A; Yamaguchi N; Natori Y; Suzuki T; Itou M; Kusakabe K; Demura R
Rinsho Byori; 1993 Jun; 41(6):666-72. PubMed ID: 7689666
[TBL] [Abstract][Full Text] [Related]
33. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report.
Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC
Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424
[TBL] [Abstract][Full Text] [Related]
34. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
[TBL] [Abstract][Full Text] [Related]
35. Graves'-Basedow disease in pregnancy. New trends in the management and guidance to reduce the risk of birth defects caused by antithyroid drugs.
Laurberg P; Andersen SL
Nuklearmedizin; 2015; 54(3):106-11. PubMed ID: 26105719
[TBL] [Abstract][Full Text] [Related]
36. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
37. [Pregnancy and the thyroid gland].
Lieutaud H
Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
[TBL] [Abstract][Full Text] [Related]
38. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
39. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed.
Kempers MJ; van Tijn DA; van Trotsenburg AS; de Vijlder JJ; Wiedijk BM; Vulsma T
J Clin Endocrinol Metab; 2003 Dec; 88(12):5851-7. PubMed ID: 14671180
[TBL] [Abstract][Full Text] [Related]
40. Hyperthyroidism of Graves' disease: evidence for only unilateral involvement of the thyroid gland in a 31-year-old female patient.
Dimai HP; Ramschak-Schwarzer S; Lax S; Lipp RW; Leb G
J Endocrinol Invest; 1999 Mar; 22(3):215-9. PubMed ID: 10219891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
